Distinct Healthcare Hldg Ltd (2677) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Distinct Healthcare Hldg Ltd HK$50.62, price HK$22.38, upside +126.2%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Distinct Healthcare Hldg Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Sep 27, 2026.
How to read this chart
8‑month range HK$21.04 – HK$67.90 · fair‑value band HK$34.10 – HK$77.86 · the HK$22.38 price screens below the HK$50.62 fair value. As of Sep 27, 2026.
Follow Distinct Healthcare Hldg in your weekly email
Every Wednesday you see whether Distinct Healthcare Hldg is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Distinct Healthcare Holdings Limited operates as a healthcare service provider in China. The company offers medical services in the areas of pediatrics, dentistry, eye care, dermatology, ear, nose and throat, general surgery, women's health, physical therapy and rehabilitation, psychiatry and psychology, and internal healthcare.
Show more
Distinct Healthcare Holdings Limited operates as a healthcare service provider in China. The company offers medical services in the areas of pediatrics, dentistry, eye care, dermatology, ear, nose and throat, general surgery, women's health, physical therapy and rehabilitation, psychiatry and psychology, and internal healthcare. It provides professional healthcare services that cover a range of specialties through its private healthcare service institutions and tele-healthcare service platform. The company operates through its brand name and its tele-healthcare service platform, Distinct HealthCare. The company's platforms include Hospital Management System ("HMS"), Distinct Management System ("DMS") and Distinct Data Platform. Its platform HMS is a cloud-based electronic medical record system; DMS is a comprehensive patient management system to streamline and standardize the process of patient management and its Distinct Data Platform aggregates all data from different realms such as user background and activity data, anonymized clinical data, operation data and financial data. Distinct HealthCare has a strategic partnership with Tencent Holdings Limited. Distinct Healthcare Holdings Limited was founded in 2012 and is based in Shenzhen, China.
Stock analysis
Distinct Healthcare Hldg Ltd (2677) currently trades at HK$22.38, while our model-based Fair Value estimate is HK$50.62, implying the stock looks roughly 55.8% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of HK$70.07 per share, and 17 of the 21 models we run sit above the HK$22.38 price.
Bear case: the Economic Profit group reads lowest at HK$9.35, and 4 of the 21 models stay below the price. Evidence for this calculation is medium.
Scenario range: HK$34.10 (bear) to HK$77.86 (bull), the price of HK$22.38 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Distinct Healthcare Hldg Ltd reported revenue of 1.1B CNY in FY2025 versus 473M CNY in FY2022, a compound +31.0%/yr. Reported net income was 135M CNY in FY2025.
Key figures
Market cap HK$1.9B (≈ $241M) · P/E ratio 12.1 · P/S ratio 1.54 · Net margin 12.7% · Return on assets (EBIT) −5.1% · Operating margin 2.7% · Revenue (TTM) 1.1B CNY · Free cash flow 146M CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at 21% fair-value upside, at 126%, 2677 screens cheaper than that median.
Fair Value models
Bear HK$34.10Fair Value HK$50.62Bull HK$77.86
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+11.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.0%
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−31.9% (2022) → 2.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−5.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in CNY, China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about −7.0% a year for the price.
Compare Distinct Healthcare Hldg Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 250 stocks
Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside+126.2% · Top 25%
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets1.3% · Below median
Net margin (TTM)12.7% · Top 25%
Operating margin (TTM)2.7% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)12.1× · Cheapest 25%
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)1.52× · Pricier than median
P/FCF11.1× · Cheaper than median
EV/EBITDA14.5× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)100· sector 33
FUTURE (revenue growth)0· sector 26
PAST (return on equity)0· sector 30
HEALTH (low debt)0· sector 89
DIVIDEND (yield)0· sector 41
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Distinct Healthcare Hldg Ltd (2677) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of HK$50.62 versus a price of HK$22.38, about +126% upside (undervalued).
What is the fair value of 2677?
Our model-based fair value for Distinct Healthcare Hldg Ltd is HK$50.62 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$22.38.
What is the quality score of 2677?
Distinct Healthcare Hldg Ltd has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Distinct Healthcare Hldg Ltd (2677)?
Our model-based price target is the fair value of HK$50.62 (as of Sep 27, 2026) from 21 valuation models. Cautious scenario HK$34.10, optimistic scenario HK$77.86. It is a calculation from audited fundamentals, not an analyst target.
What is the Distinct Healthcare Hldg Ltd stock forecast for 2026?
Our models put fair value at HK$50.62, about +126% upside versus a price of HK$22.38 (undervalued). Cautious scenario HK$34.10, optimistic scenario HK$77.86. The calculation is refreshed regularly with new filings.
What is the revenue of Distinct Healthcare Hldg Ltd (2677)?
Distinct Healthcare Hldg Ltd reported trailing-twelve-month revenue of about 1.1B CNY (latest available figure, as of Sep 27, 2026).
What growth is priced into Distinct Healthcare Hldg Ltd (2677)?
For today's price to be fair in a discounted-cash-flow model, Distinct Healthcare Hldg Ltd would have to grow free cash flow by -5.4 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +31.0 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of 2677 use?
Our models discount Distinct Healthcare Hldg Ltd at 13.3 %: a base by market capitalisation (micro), country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Distinct Healthcare Hldg Ltd that is -5.4 % per year a year over ten years, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Distinct Healthcare Hldg Ltd (2677) delivered so far?
Over the past 3 years revenue at Distinct Healthcare Hldg Ltd grew +31.0 % a year. The price currently implies -5.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Distinct Healthcare Hldg Ltd (2677) growing?
The median revenue growth in the sector is +2.0 % a year. That is the yardstick for the growth priced into Distinct Healthcare Hldg Ltd (-5.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Distinct Healthcare Hldg Ltd (2677)?
The free-cash-flow yield on the price is 11.83 %: that much free cash flow Distinct Healthcare Hldg Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Distinct Healthcare Hldg Ltd (2677)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Distinct Healthcare Hldg Ltd it is HK$50.62 per share (as of Sep 27, 2026), against a price of HK$22.38. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is Distinct Healthcare Hldg Ltd stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 2677 trades below its calculated fair value: price HK$22.38, fair value HK$50.62, a gap of about +126% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 2677?
No. The price is what the market pays today (HK$22.38); the fair value is what the company's own numbers justify (HK$50.62). For Distinct Healthcare Hldg Ltd the two are HK$28.24 per share apart. That gap is exactly why we show both numbers side by side.
How much is Distinct Healthcare Hldg Ltd worth?
The market values Distinct Healthcare Hldg Ltd at about HK$1.9B (market capitalisation, as of Sep 27, 2026). Per share that is HK$22.38; our models calculate a fair value of HK$50.62 per share.
What do the bullish and bearish scenarios say about 2677?
Our models span a range for Distinct Healthcare Hldg Ltd: cautious scenario HK$34.10, base HK$50.62, optimistic HK$77.86 per share (as of Sep 27, 2026, price HK$22.38). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 2677?
Distinct Healthcare Hldg Ltd trades at a price-to-earnings ratio of 12.1 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$50.62 is built from several models across several years. Other multiples: P/S 1.5, EV/EBITDA 14.5.
How solid is the balance sheet of Distinct Healthcare Hldg Ltd (2677)?
Balance-sheet figures for Distinct Healthcare Hldg Ltd (as of Sep 27, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
Which stocks are comparable to Distinct Healthcare Hldg Ltd?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Distinct Healthcare Hldg Ltd stock attractive at the current price?
The data as of Sep 27, 2026: price HK$22.38, calculated fair value HK$50.62 (+126%), Quality Score 64/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 2677 calculated?
We run Distinct Healthcare Hldg Ltd through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$50.62, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. Distinct Healthcare Hldg Ltd currently trades 56 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Distinct Healthcare Hldg Ltd (2677)?
The closing price on Sep 30, 2026 was HK$22.38. Our model-based fair value is HK$50.62, about +126% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Distinct Healthcare Hldg Ltd right now?
The price is below even our cautious bear case (HK$34.10). The market is more pessimistic than our downside scenario. Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (HK$34.10 to HK$77.86) leaves room in how you read the outcome.
Key figures of Distinct Healthcare Hldg Ltd
How large is the market capitalisation of Distinct Healthcare Hldg Ltd (2677)?
The market capitalisation of Distinct Healthcare Hldg Ltd is HK$1.9B (≈ $241M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Distinct Healthcare Hldg Ltd (2677)?
The price-to-sales ratio of Distinct Healthcare Hldg Ltd is 1.54 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Distinct Healthcare Hldg Ltd (2677)?
The net margin of Distinct Healthcare Hldg Ltd is 12.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Distinct Healthcare Hldg Ltd (2677)?
On an EBIT basis the return on assets of Distinct Healthcare Hldg Ltd is −5.1% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Distinct Healthcare Hldg Ltd (2677)?
The operating margin of Distinct Healthcare Hldg Ltd is 2.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
Free · no account needed
Watch Distinct Healthcare Hldg Ltd in the live analysis
One click puts Distinct Healthcare Hldg Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
